MedTrace Logo

Effect of Preservative-free Low-dose Hyaluronic Acid-containing Salt Solution on Dry Eye Disease

NCT03888183 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 334

Last updated 2019-09-19

No results posted yet for this study

Summary

This trial is a randomized, parallel-group, double-blind, controlled clinical trial to evaluate the effect of hyaluronic acid (HA) on dry eye disease.

Conditions

  • Dry Eye

Interventions

DRUG

salt solution without 0.15% HA

received AIM Artificial Tears (4 to 8 times per day) with 12 weeks

DRUG

preservative-free 0.15% HA

received Per-Young Eye Drops (4 to 8 times per day) with 12 weeks

Sponsors & Collaborators

  • Chang Gung Memorial Hospital

    lead OTHER

Principal Investigators

  • Ing-Chou Lai, MD · Department of Ophthalmology, Chang Gung Memorial Hospital, Kaohsiung, Taiwan

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-04-17
Primary Completion
2020-01-22
Completion
2020-03-22

Countries

  • Taiwan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03888183 on ClinicalTrials.gov